Skip to main content
Clinical Trials/NCT00997126
NCT00997126
Completed
Phase 4

Propofol Versus Alfentanil Versus Nitrous Oxide for Moderate Procedural Sedation in the Emergency Department

Hennepin Healthcare Research Institute1 site in 1 country126 target enrollmentOctober 2009

Overview

Phase
Phase 4
Intervention
Propofol
Conditions
Sedation
Sponsor
Hennepin Healthcare Research Institute
Enrollment
126
Locations
1
Primary Endpoint
Number of Participants With Sub-clinical Respiratory Depression and Clinical Events Associated With Respiratory Depression During the Sedation Procedure
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This is a clinical trial of propofol and alfentanil as agents for moderated procedural sedation in patients undergoing sedation in the emergency department (ED).

Detailed Description

This was initially going to be a trial of propofol vs alfentanil vs nitrous oxide, but our use of nitrous oxide was discontinued before the trial began and the trial was conducted with only two arms

Registry
clinicaltrials.gov
Start Date
October 2009
End Date
April 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adults undergoing moderate procedural sedation in the Emergency Department

Exclusion Criteria

  • Age \<18 years
  • Pregnancy
  • Intoxication
  • Cannot give informed consent
  • Allergy to any of the three study medications
  • ASA physical status score \> 2
  • Patients who require deep procedural sedation

Arms & Interventions

Propofol

Propofol 1m g/kg IV followed by 0.5 mg/kg IV prn sedation

Intervention: Propofol

Alfentanil

Sedation using alfentanil 10 ug/kg followed by 5 ug/kg prn sedation

Intervention: Alfentanil

Outcomes

Primary Outcomes

Number of Participants With Sub-clinical Respiratory Depression and Clinical Events Associated With Respiratory Depression During the Sedation Procedure

Time Frame: From one minute prior to start of procedure until the patient has returned to baseline mental status after the conclusion of the sedation procedure (~3-60 minutes depending on procedure duration)

Secondary Outcomes

  • Depth of Sedation Measured Using the OAAS Scale(Single measurement during sedation procedure)
  • Patient Reported Pain(Single measurement immediately after patient returns to baseline mental status after sedation procedure)
  • Patient Reported Recall of the Procedure(Single measurement immediately after patient returns to baseline mental status after sedation procedure)
  • Time to Return of Baseline Mental Status From Start of Procedure in Minutes(Single time point after completion of sedation procedure, measured from start of procedure until the patient returns to baseline mental status up to 24 hours)

Study Sites (1)

Loading locations...

Similar Trials